DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Nilotinib is effective in imatinib and sunitinib resistant GIST: a case report.

Author(s): Dizdar O, Yalcin S

Affiliation(s): Department of Medical Oncology, Hacettepe University, Institute of Oncology, Ankara, Turkey.

Publication date & source: 2011-05, Hepatogastroenterology., 58(107-108):859-60.

Publication type: Case Reports

We report on the case of a 65-year-old male patient who had an imatinib- and sunitinib-resistant gastro-intestinal stromal tumor. Partial response was achieved with nilotinib treatment given in a compassionate-use program. Efficacy and tolerability of nilotinib in patients with refractory gastrointestinal stromal tumor are briefly discussed.

Page last updated: 2011-12-09

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017